SAM
IMGN

Shamrock Asset Management’s Immunogen Inc IMGN Stock Holding History

Shamrock Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,500
Closed -$5K – 277
2016
Q2 		$5K Hold
1,500
– – ﹤0.01% 240
2016
Q1 		$13K Hold
1,500
– – 0.01% 205
2015
Q4 		$20K Hold
1,500
– – 0.01% 197
2015
Q3 		$14K Hold
1,500
– – 0.01% 197
2015
Q2 		$22K Hold
1,500
– – 0.01% 184
2015
Q1 		$13K Hold
1,500
– – 0.01% 215
2014
Q4 		$9K Hold
1,500
– – ﹤0.01% 209
2014
Q3 		$16K Hold
1,500
– – 0.01% 191
2014
Q2 		$18K Hold
1,500
– – 0.01% 220
2014
Q1 		$22K Buy
+1,500
New +$23.6K 0.01% 210

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Shamrock Asset Management's IMGN Position: Q3 2016 in Review

Shamrock Asset Management sold out of Immunogen Inc (IMGN) in Q3 2016, closing a stake of 1,500 shares — an estimated $5K sold.

Shamrock Asset Management first reported a position in IMGN in Q1 2014 and held it in 10 quarters. The position peaked at $22K in Q2 2015. 155 funds tracked by Wall St. Rank hold IMGN as of Q3 2016.

  • Shamrock Asset Management reported no remaining Immunogen Inc position as of Q3 2016 after selling out during the quarter.
  • Shamrock Asset Management sold 1,500 Immunogen Inc shares in Q3 2016, an estimated $5K.
  • Shamrock Asset Management first reported a position in Immunogen Inc in Q1 2014 and held it in 10 quarters.
  • Shamrock Asset Management's Immunogen Inc position peaked at $22K in Q2 2015.
  • 155 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2016.

Based on Shamrock Asset Management's 13F filing for Q3 2016, filed 9 Nov 2016.